Detalhe da pesquisa
1.
Latent human herpesvirus 6 is reactivated in CAR T cells.
Nature
; 623(7987): 608-615, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37938768
2.
Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent, and young adult patients with B-cell acute lymphoblastic leukemia.
Pediatr Nephrol
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507119
3.
Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells.
Gene Ther
; 30(3-4): 222-231, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34997202
4.
Hemophagocytic lymphohistiocytosis-like toxicity (carHLH) after CD19-specific CAR T-cell therapy.
Br J Haematol
; 194(4): 701-707, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34263927
5.
Hematopoietic cell transplant for reversal of liver fibrosis in a pediatric patient with erythropoietic protoporphyria.
Pediatr Transplant
; 25(6): e13966, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33405342
6.
A quality improvement project to improve pediatric medical provider sleep and communication during night shifts.
Int J Qual Health Care
; 31(8): 633-638, 2019 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423134
7.
Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-2, and Haploidentical Natural Killer Cells.
Biol Blood Marrow Transplant
; 23(11): 1910-1917, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28733263
8.
INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young Adults.
Transplant Cell Ther
; 2024 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588880
9.
INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities.
Transplant Cell Ther
; 30(1): 38-55, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37821079
10.
A tour de force provides novel insights into CD19-CAR T cell resistance mechanisms.
Cell Rep Med
; 4(2): 100949, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812888
11.
Preventing relapse after CD19 CAR T-cell therapy for pediatric ALL: the role of transplant and enhanced CAR T cells.
Hematology Am Soc Hematol Educ Program
; 2023(1): 91-96, 2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066941
12.
What is Next in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia.
Lymphatics
; 1(1): 34-44, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38269058
13.
Integration of Palliative Care in Hematopoietic Cell Transplant: Pediatric Patient and Parent Needs and Attitudes.
J Pain Symptom Manage
; 66(3): 248-257, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37302531
14.
Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent and young adult patients with B-cell acute lymphoblastic leukemia.
Res Sq
; 2023 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37886451
15.
Integrome signatures of lentiviral gene therapy for SCID-X1 patients.
Sci Adv
; 9(40): eadg9959, 2023 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801507
16.
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
Transplant Cell Ther
; 29(7): 438.e1-438.e16, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906275
17.
Chimeric Antigen Receptor T-cell Therapy: Current Status and Clinical Outcomes in Pediatric Hematologic Malignancies.
Hematol Oncol Clin North Am
; 36(4): 701-727, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780062
18.
Impact of High Disease Burden on Survival in Pediatric Patients with B-ALL Treated with Tisagenlecleucel.
Transplant Cell Ther
; 28(2): 73.e1-73.e9, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875402
19.
Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19-CAR T Cell Therapy.
Front Oncol
; 12: 845540, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35356197
20.
Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients.
Transplant Cell Ther
; 28(5): 262.e1-262.e10, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35151936